Artificial cornea implant aims to restore sight in the blind

NCT ID NCT05694247

Terminated Disease control Sponsor: CorNeat Vision Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tested a device called the CorNeat KPro, an artificial cornea, in 15 legally blind adults who could not get a standard cornea transplant. The goal was to see if the implant is safe and can improve vision. The study was terminated early, so full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CorNeat KPro (artificial cornea implant)
What this could lead to: If successful, this device could offer a new option to restore vision in people with corneal blindness who cannot have a standard cornea transplant.
What could go wrong: This was a small, early trial that was terminated, so results are limited. The device may fail to stay in place or cause complications like infection or rejection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORNEAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

corneal disorder Corneal Injuries Corneal Opacity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORNEAL DISEASE CORNEAL INJURIES CORNEAL OPACITY

Contacts and locations

Locations

Amsterdam UMC - Location AMC

Amsterdam, 1105 AZ, Netherlands
CHU de Montpellier

Montpellier, 34295, France
Hopital Fondation Adolphe de Rothschild

Paris, France
Rabin Medical Center - Beilinson

Petah Tikva, Israel, 4941492, Israel
UHN - University Health Network

Toronto, Ontario, M5T 2S8, Canada
University of British Columbia

Vancouver, British Columbia, V5Z 3N9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.